ARTICLE | Company News
Cellceutix autoimmune news
August 2, 2010 7:00 AM UTC
Cellceutix said it retained Destum Partners to assist in finding a development partner for its preclinical psoriasis candidate KM-133. Further details were not disclosed. ...